Introducing Dr. Sara Tai

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingIntroducing Dr. Sara Tai

Albert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101

Albert Labs approved by Health Canada for psilocybin possession, production and delivery license

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs approved by Health Canada for psilocybin possession, production and delivery license

Albert Labs Granted Health Canada Licence

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs Granted Health Canada Licence

Albert Labs announces partnership with drug safety & toxicology experts at the University of CESPU

Albert Labs, today announced that it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange ("CSE") in coordination with its previously announced transaction with ME Resource Corp ("MEC"). Subject to final CSE approval, the Common Shares of the Company are expected to commence trading on the CSE under the ticker "ABRT" early in the new year.

Continue ReadingAlbert Labs announces partnership with drug safety & toxicology experts at the University of CESPU